 |
인쇄하기
취소
|
Kim to head pharmaceutical group
Kim Dae-joong, CEO of Daiichi-Sankyo Korea, was elected president of the Korea Japanese Pharmaceutical Association (KJPA) as of March 13, the association said.
Kim will replace incumbent Hukuyama Mashashi, CEO of Daiichi-Kirin Pharma, who is scheduled to return to the headquarters in Tokyo next month.
The KRPIA is an association of Japanese research-oriented pharmaceutical companies devel...
Kim will replace incumbent Hukuyama Mashashi, CEO of Daiichi-Kirin Pharma, who is scheduled to return to the headquarters in Tokyo next month.
The KRPIA is an association of Japanese research-oriented pharmaceutical companies devel...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.